The CRISPR/Cas9 Minipig—A Transgenic Minipig to Produce Specific Mutations in Designated Tissues

Research in large animal models has been hampered by the complexity to introduce new gene alterations, but this has been simplified by the discovery of the CRISPR/Cas system. Here, we have cloned a Cas9 minipig to generate a porcine model for pre-clinical research. Six viable piglets were produced and backcrossed to Göttingen minipigs for two generations. Primary cells from different organs were isolated, and multiple gene alterations were performed by CRISPR in vitro. In vivo activation of the Cas9 expression was conducted by viral delivery of the FlpO expression to the skin. Overall, we successfully cloned a Cas9-expressing minipig and confirmed gene alterations introduced by the CRISPR/Cas system to porcine cells.

Abstract

The generation of large transgenic animals is impeded by complex cloning, long maturation and gastrulation times. An introduction of multiple gene alterations increases the complexity. We have cloned a transgenic Cas9 minipig to introduce multiple mutations by CRISPR in somatic cells. Transgenic Cas9 pigs were generated by somatic cell nuclear transfer and were backcrossed to Göttingen Minipigs for two generations. Cas9 expression was controlled by FlpO-mediated recombination and was visualized by translation from red to yellow fluorescent protein. In vitro analyses in primary fibroblasts, keratinocytes and lung epithelial cells confirmed the genetic alterations executed by the viral delivery of single guide RNAs (sgRNA) to the target cells. Moreover, multiple gene alterations could be introduced simultaneously in a cell by viral delivery of sgRNAs. Cells with loss of TP53, PTEN and gain-of-function mutation in KRAS^G12D showed increased proliferation, confirming a transformation of the primary cells. An in vivo activation of Cas9 expression could be induced by viral delivery to the skin. Overall, we have generated a minipig with conditional expression of Cas9, where multiple gene alterations can be introduced to somatic cells by viral delivery of sgRNA. The development of a transgenic Cas9 minipig facilitates the creation of complex pre-clinical models for cancer research. View Full-Text

Keywords: CRISPR; cancer; animal models; porcine model; lung cancer; handmade cloning; TP53; STK11; KRAS; Göttingen minipigs

▼ Show Figures

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited

Supplementary Material

Supplementary File 1:
ZIP-Document (ZIP, 3271 KiB)

Share and Cite

MDPI and ACS Style

Berthelsen, M.F.; Riedel, M.; Cai, H.; Skaarup, S.H.; Alstrup, A.K.O.; Dagnæs-Hansen, F.; Luo, Y.; Jensen, U.B.; Hager, H.; Liu, Y.; Callesen, H.; Vendelbo, M.H.; Jakobsen, J.E.; Thomsen, M.K. The CRISPR/Cas9 Minipig—A Transgenic Minipig to Produce Specific Mutations in Designated Tissues. Cancers 2021, 13, 3024. https://doi.org/10.3390/cancers13123024

AMA Style

Berthelsen MF, Riedel M, Cai H, Skaarup SH, Alstrup AKO, Dagnæs-Hansen F, Luo Y, Jensen UB, Hager H, Liu Y, Callesen H, Vendelbo MH, Jakobsen JE, Thomsen MK. The CRISPR/Cas9 Minipig—A Transgenic Minipig to Produce Specific Mutations in Designated Tissues. Cancers. 2021; 13(12):3024. https://doi.org/10.3390/cancers13123024

Chicago/Turabian Style

Berthelsen, Martin F., Maria Riedel, Huiqiang Cai, Søren H. Skaarup, Aage K.O. Alstrup, Frederik Dagnæs-Hansen, Yonglun Luo, Uffe B. Jensen, Henrik Hager, Ying Liu, Henrik Callesen, Mikkel H. Vendelbo, Jannik E. Jakobsen, and Martin K. Thomsen. 2021. "The CRISPR/Cas9 Minipig—A Transgenic Minipig to Produce Specific Mutations in Designated Tissues" Cancers 13, no. 12: 3024. https://doi.org/10.3390/cancers13123024

Find Other Styles

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Abstract views Pdf views Html views

Article Menu

The CRISPR/Cas9 Minipig—A Transgenic Minipig to Produce Specific Mutations in Designated Tissues

Simple Summary

Abstract

Supplementary Material

Share and Cite

Article Metrics

Article Access Statistics

Article Access Map by Country/Region

Further Information

Guidelines

MDPI Initiatives

Follow MDPI